2.22
price up icon1.83%   0.04
after-market Handel nachbörslich: 2.19 -0.03 -1.35%
loading

Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 0.231 - -
Operating Expenses
23.34%
2.309
1.872 1.674 1.59 1.914
Operating Income/Loss
23.34%
-2.309
-1.872 -1.674 -1.59 -1.914
Nonoperating Income/Loss
750.00%
0.143
-0.022 - 0.066 0.068
Income/Loss From Continuing Operations Before Tax
22.44%
-2.166
-1.769 5.755 -1.524 -1.846
Income/Loss From Continuing Operations After Tax
22.44%
-2.166
-1.769 -1.626 -1.524 -1.846
Net Income/Loss
22.44%
-2.166
-1.769 -1.626 -1.524 -1.846
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11.32%
4.7949
4.3073 0.1166 0.99 0.5102
Diluted Average Shares
11.32%
4.7949
4.3073 0.1166 0.99 0.5102
Basic Earnings Per Share
9.76%
-0.45
-0.41 -0.85 -1.54 -3.62
Diluted Earnings Per Share
9.76%
-0.45
-0.41 -0.85 -1.54 -3.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):